Neogen Chemicals Ltd

Neogen Chemicals Ltd announced rating actions from multiple agencies reflecting a significant improvement in its financial risk profile driven by a Qualified Institutional Placement (QIP). CRISIL Ratings Limited reaffirmed the CRISIL A-/Stable rating, revising the outlook from ‘Negative’ for Total Bank Loan Facilities of Rs 680 Crore and Non-Convertible Debentures of Rs 200 Crore, alongside reaffirming the existing CRISIL A-/Negative rating for the same instruments; CRISIL Ratings Limited also reaffirmed the CRISIL BBB+/Stable rating, revising the outlook from ‘Negative’ for Total Bank Loan Facilities of Rs 1,150 Crore and reaffirmed the existing CRISIL BBB+/Negative rating for the same instruments, further including ratings for Cash Credit facilities from State Bank of India, HDFC Bank Limited, Axis Bank Limited, and IDBI Bank Limited (all CRISIL A-/Stable), a Letter of Credit from State Bank of India (CRISIL A2+), Long Term Loans from HDFC Bank Limited, Axis Bank Limited, and Bandhan Bank Limited (CRISIL A-/Stable), a Proposed Long Term Bank Loan Facility (CRISIL A-/Stable), Working Capital Demand Loans from IDBI Bank Limited and Bandhan Bank Limited (CRISIL A2+), a Working Capital Term Loan from HDFC Bank Limited (CRISIL A-/Stable), a Long Term Bank Facility from State Bank of India (BBB+/Stable), and a Working Capital Facility from Axis Bank Limited (BBB+/Stable), with no enhancements, assignments, or withdrawals noted.

Neogen Chemicals Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company's securities will be closed for designated persons, their immediate relatives, connected persons, and legitimate insiders from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.

Neogen Chemicals Limited announced that its Fund-Raising Committee approved the allotment of 26,60,753 equity shares to eligible Qualified Institutional Buyers (QIBs) at a price of Rs 2,255 per share, raising Rs 599.9998 crore. The company's paid-up equity share capital increased from Rs 27.38 crore to Rs 30.04 crore as a result of the Qualified Institutional Placement (QIP).

Neogen Chemicals Limited announced the completion of a qualified institutional placement (QIP) of 26,60,753 equity shares to eligible institutional buyers at a price of Rs 2,255 per share, raising Rs 599.9998 crore. The company's paid-up equity share capital increased from Rs 27.38 crore to Rs 30.04 crore as a result of the allotment. A list of allottees holding more than 5% of the shares is included in an annexure, and further details are available on the company's website.

Neogen Chemicals Limited announced that its Fund-Raising Committee has approved the closure of a qualified institutions placement (QIP) for 26,60,753 equity shares, which opened on September 10, 2026, and determined an issue price of Rs 2,255 per share, including a premium of Rs 2,245 per share, to be allotted to eligible qualified institutional buyers.

Neogen Chemicals Limited said its Fund-Raising Committee approved a qualified institutions placement of equity shares with a floor price of Rs 2,189.73 per share, following approvals from the company's board on July 24, 2026, and shareholders on August 21, 2026. The company may offer a discount of not more than 5% on the floor price, and the issue price will be determined in consultation with lead managers, with a preliminary placement document to be filed with the BSE Limited and National Stock Exchange of India Limited on September 10, 2026.

Neogen Chemicals Limited informed the BSE Limited and National Stock Exchange of India Limited that its register of members and share transfer register will be closed from August 14, 2026, to August 21, 2026, for dividend purposes, with August 13, 2026, set as the record date/cutoff date for remote e-voting and final dividend eligibility for the financial year ended March 31, 2026.

Neogen Chemicals has received reasonable assurance that its Business Responsibility and Sustainability Report (BRSR) data for the period April 1, 2025 – March 31, 2026, and related historical data, is presented fairly, according to an assessment by independent assurance provider Bureau Veritas. The assessment, conducted using ISAE 3000 (Revised) standards, covered nine core BRSR indicators related to environmental impact, employee wellbeing, governance, and customer/supplier fairness. Bureau Veritas’s evaluation included site visits, interviews with key personnel, and a review of data collection systems, confirming compliance with Securities and Exchange Board of India (SEBI) regulations. The assurance does not extend to activities outside the reporting period or operations of subsidiaries outside the defined scope.

Neogen Chemicals announced that the 37th Annual General Meeting(AGM) of the company will be held on 21 August 2026.

Net profit of Neogen Chemicals rose 66.76% to Rs 17.11 crore in the quarter ended June 2026 as against Rs 10.26 crore during the previous quarter ended June 2025. Sales rose 34.04% to Rs 250.29 crore in the quarter ended June 2026 as against Rs 186.73 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales250.29186.73 34 OPM %19.2716.87 - PBDT31.4820.07 57 PBT23.2814.29 63 NP17.1110.26 67 Powered by Capital Market - Live